Recent clinical advances in inhalation therapy

Symposium
Chairs: C. Darquenne (La Jolla, United States of America), F. Lavorini (Firenze (FI), Italy)
Aims: to present the exponential increase in aerosol science for targeting drugs to the respiratory tract in many different respiratory diseases, which are now being translated into clinical trials; to focus on the clinical advances that have arisen from aerosol science research.

Cons - governments should impose targets for healthcare professionals to switch their respiratory disease patients to inhalers with a low global warming potential O. Usmani (London, United Kingdom)
Pros: governments should impose targets for healthcare professionals to switch their respiratory disease patients to inhalers with a low global warming potential C. Janson (Uppsala, Sweden)
Mechanically ventilated patients R. Dhand (Knoxville, United States of America)
Paediatric airway diseases W. van Aalderen (Amsterdam, Netherlands)
Non-cystic fibrosis bronchiectasis S. Antoniu (Iasi (Iasi), Romania)